Skip to main content
. Author manuscript; available in PMC: 2017 Jun 28.
Published in final edited form as: Handb Clin Neurol. 2014;123:265–283. doi: 10.1016/B978-0-444-53488-0.00012-2

Table 12.3.

Detection of varicella-zoster virus (VZV) DNA in saliva

Clinical condition Prevalence of VZV DNA
in saliva		 Reference
Acute herpes zoster 54/54 (100%) Mehta et al. (2008)
Acute herpes zoster (Ramsay Hunt syndrome) 13/25 (52%); 7/28 (25%) Furuta et al. (2001); Aizawa et al. (2004)
25/42 (60%); 9/10 (90%) Yamakawa et al. (2007); Lackner et al. (2010)
Acute peripheral facial paralysis without rash 17/31 (55%); 3/10 (30%); 2/10 (20%) Furuta et al. (2001, 2005); Lackner et al. (2010)
Delayed facial palsy after orofacial surgery 4/8 (50%) Furuta et al. (2000)
Elderly (>age 60) with history of zoster 21/32 (66%) Nagel et al. (2011c)
Elderly (>age 60) with no history of zoster 2/17 (11%) Nagel et al. (2011c)
Elderly (>age 60) after immunization 18/36 (50%) Pierson et al. (2011)
Healthy astronauts during and after space flight 8/8 (100%); 2/3 (66%) Mehta et al. (2004); Cohrs et al. (2008)